CN Patent

CN105164161A — 神经活性类固醇、组合物、及其用途

Assigned to Sage Therapeutics Inc · Expires 2015-12-16 · 10y expired

What this patent protects

提供评估或治疗患者(例如患有本文所述障碍的患者)的方法，其包括：a)任选地，获取患者样品；b)获得对该样品的评估和/或评估该样品相比于参考标准在24(S)-羟基胆固醇水平上的变化。

USPTO Abstract

提供评估或治疗患者(例如患有本文所述障碍的患者)的方法，其包括：a)任选地，获取患者样品；b)获得对该样品的评估和/或评估该样品相比于参考标准在24(S)-羟基胆固醇水平上的变化。

Drugs covered by this patent

Patent Metadata

Patent number
CN105164161A
Jurisdiction
CN
Classification
—
Expires
2015-12-16
Drug substance claim
No
Drug product claim
No
Assignee
Sage Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.